Topical use of tranexamic acid: Are there concerns for cytotoxicity?

Tranexamic acid (TXA) has revolutionized modern blood management in orthopaedic surgery, especially in total joint arthroplasty, by significantly reducing blood loss and transfusion rates. It is an antifibrinolytic agent and a synthetic derivative of the amino acid lysine, which can inhibit the acti...

Descripción completa

Detalles Bibliográficos
Autores principales: Gkiatas, Ioannis, Kontokostopoulos, Aristeidis-Panagiotis, Tsirigkakis, Spyridon E, Kostas-Agnantis, Ioannis, Gelalis, Ioannis, Korompilias, Anastasios, Pakos, Emilios
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244960/
https://www.ncbi.nlm.nih.gov/pubmed/35949709
http://dx.doi.org/10.5312/wjo.v13.i6.555

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244960/
https://www.ncbi.nlm.nih.gov/pubmed/35949709
http://dx.doi.org/10.5312/wjo.v13.i6.555

Ejemplares similares